A novel pan-PI3K inhibitor KTC1101 synergizes with anti-PD-1 therapy by targeting tumor suppression and immune activation
Article in Molecular Cancer (March 2024)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Article in Molecular Cancer (March 2024)
Article in Journal of Hematology & Oncology (January 2024)
Article in Cellular Immunology (November 2023)